Vor Biopharma Inc.VORNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+71.9%
5Y CAGR+59.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+71.9%/yr
vs +127.0%/yr prior
5Y CAGR
+59.6%/yr
Recent acceleration
Acceleration
-55.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
10.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $327.69M | +251.2% |
| 2024 | $93.31M | -1.1% |
| 2023 | $94.31M | +46.1% |
| 2022 | $64.55M | +35.8% |
| 2021 | $47.53M | +50.3% |
| 2020 | $31.62M | +410.0% |
| 2019 | $6.20M | +154.8% |
| 2018 | $2.43M | - |